Rapid suppression of HBV replication before related liver transplantation in a patient with HDV superinfection. Clinical case report
Chronic hepatitis B virus (HBV) infection is one of the main problems of modern transplantology and transplant hepatology, often leading to potentially fatal complications. The only definitive treatment for HBV-related cirrhosis is liver transplantation. However, recurrence of HBV after transplantat...
| 發表在: | Вестник трансплантологии и искусственных органов |
|---|---|
| Main Authors: | U. R. Salimov, P. Balachandran, D. B. Tulyaganov, M. R. Ruzibakieva, F. A. Khadjibaev, K. E. Anvarov |
| 格式: | Article |
| 語言: | 俄语 |
| 出版: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2024-09-01
|
| 主題: | |
| 在線閱讀: | https://journal.transpl.ru/vtio/article/view/1785 |
相似書籍
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate in a cohort of patients with HBV infection: A retrospective study
由: Giacomo Stroffolini, et al.
出版: (2024-02-01)
由: Giacomo Stroffolini, et al.
出版: (2024-02-01)
Reconsidering treatment indications for chronic hepatitis B: Insights from the TORCH-B roll-over study: Editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
由: Chih-Wen Wang, et al.
出版: (2025-04-01)
由: Chih-Wen Wang, et al.
出版: (2025-04-01)
Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study
由: Pei-Yuan Su, et al.
出版: (2021-11-01)
由: Pei-Yuan Su, et al.
出版: (2021-11-01)
Antiviral Efficacy and Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B
由: Tuvshinbayar Narangerel, et al.
出版: (2020-12-01)
由: Tuvshinbayar Narangerel, et al.
出版: (2020-12-01)
Cost–effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece
由: Emmanouil Sinakos, et al.
出版: (2024-02-01)
由: Emmanouil Sinakos, et al.
出版: (2024-02-01)
Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate in patients with Hepatitis B: a network meta-analysis
由: Zekun Liu, et al.
出版: (2023-11-01)
由: Zekun Liu, et al.
出版: (2023-11-01)
Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
由: Jianming Yang, et al.
出版: (2023-01-01)
由: Jianming Yang, et al.
出版: (2023-01-01)
Fanconi Syndrome Due to Tenofovir Disoproxil Fumarate in a Patient with Chronic Hepatitis B Induced Cirrhosis: A Case Report
由: Milad Khodabakhshi, et al.
出版: (2024-11-01)
由: Milad Khodabakhshi, et al.
出版: (2024-11-01)
Decrease in HBsAg After TAF Switching from Entecavir During Long-Term Treatment of Chronic Hepatitis B Virus Infection
由: Kazuto Tajiri, et al.
出版: (2024-12-01)
由: Kazuto Tajiri, et al.
出版: (2024-12-01)
Metabolic Outcomes of Changing From Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine to Rilpivirine/Tenofovir Alafenamide/Emtricitabine: A Longitudinal Study
由: Ping‐Feng Wu, et al.
出版: (2024-12-01)
由: Ping‐Feng Wu, et al.
出版: (2024-12-01)
Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort
由: Bernard Surial, et al.
出版: (2019-10-01)
由: Bernard Surial, et al.
出版: (2019-10-01)
Renal function and lipid metabolism in Japanese HIV-1-positive individuals 288 weeks after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate: a single-center, retrospective cohort study
由: Kensuke Abe, et al.
出版: (2024-02-01)
由: Kensuke Abe, et al.
出版: (2024-02-01)
Renal function in Japanese HIV-1-positive patients who switch to tenofovir alafenamide fumarate after long-term tenofovir disoproxil fumarate: a single-center observational study
由: Kensuke Abe, et al.
出版: (2021-12-01)
由: Kensuke Abe, et al.
出版: (2021-12-01)
Efficacy and Safety of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide Fumarate in Treating Acute-on-Chronic Liver Failure with Hepatitis B Virus: A Network Meta-analysis
由: Jia Liu, et al.
出版: (2025-09-01)
由: Jia Liu, et al.
出版: (2025-09-01)
Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir
由: Fa- Da Wang, et al.
出版: (2023-09-01)
由: Fa- Da Wang, et al.
出版: (2023-09-01)
Comparison of Pegylated Interferon Alfa Therapy in Combination with Tenofovir Alafenamide Fumarate or Tenofovir Disoproxil Fumarate for Treatment of Chronic Hepatitis B Patients
由: He J, et al.
出版: (2023-06-01)
由: He J, et al.
出版: (2023-06-01)
The genotoxicity of Tenofovir disoproxil fumarate in HBV-infected patients
由: Selcen Korkmaz, et al.
出版: (2018-09-01)
由: Selcen Korkmaz, et al.
出版: (2018-09-01)
Comparison of the efficacy and safety of TAF, TDF, and LdT to prevent the transmission of hepatitis B in pregnant women: A retrospective study
由: Shufang Pan, et al.
出版: (2024-02-01)
由: Shufang Pan, et al.
出版: (2024-02-01)
Factors driving decisions in the use of HIV pre-exposure prophylaxis: a real-world study in the United States
由: Yohance Whiteside, et al.
出版: (2024-12-01)
由: Yohance Whiteside, et al.
出版: (2024-12-01)
Risk of dyslipidaemia in people living with HIV who are taking tenofovir alafenamide: a systematic review and meta‐analysis
由: Jeong‐Ju Yoo, et al.
出版: (2024-09-01)
由: Jeong‐Ju Yoo, et al.
出版: (2024-09-01)
Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate
由: Shenglong Lin, et al.
出版: (2024-11-01)
由: Shenglong Lin, et al.
出版: (2024-11-01)
Lipid profile after switching from TDF (tenofovir disoproxil)-containing to TAF (tenofovir alafenamide)-containing regimen in virologically suppressed people living with HIV
由: Michał Łomiak, et al.
出版: (2023-09-01)
由: Michał Łomiak, et al.
出版: (2023-09-01)
The Effects of Antivirals for Human Immunodeficiency Virus Treatment on Renal Functions
由: Mehmet ÇABALAK, et al.
出版: (2022-05-01)
由: Mehmet ÇABALAK, et al.
出版: (2022-05-01)
Analysis of long-term safety and efficacy of nucleos(t)ide analogue therapy for chronic hepatitis B throughout pregnancy
由: Jin Shang, et al.
出版: (2021-04-01)
由: Jin Shang, et al.
出版: (2021-04-01)
Assessment of liver fibrosis in chronic hepatitis B patients under tenofovir treatment
由: Safaa G. Elmawla Ahmed, et al.
出版: (2025-04-01)
由: Safaa G. Elmawla Ahmed, et al.
出版: (2025-04-01)
Efficacy of Tenofovir Disoproxil Fumarate in Preventing Vertical Transmission of Hepatitis B in Mothers with Chronic Hepatitis B: An Evidence-Based Case Report
由: Ris Raihan Felim, et al.
出版: (2024-10-01)
由: Ris Raihan Felim, et al.
出版: (2024-10-01)
Efficacy of Tenofovir Disoproxil Fumarate in Preventing Vertical Transmission of Hepatitis B in Mothers with Chronic Hepatitis B: An Evidence-Based Case Report
由: Ris Raihan Felim, et al.
出版: (2024-07-01)
由: Ris Raihan Felim, et al.
出版: (2024-07-01)
Observation of Glomerular Filtration Change in Chronic Hepatitis B Patients Using Tenofovir Disoproxil Fumarate
由: Meltem Karslıoğlu
出版: (2024-01-01)
由: Meltem Karslıoğlu
出版: (2024-01-01)
Advanced Liver Disease Events in People with HIV and Hepatitis B Virus Coinfection Initiating Antiretroviral Therapy in the United States
由: Ching-Yi Chuo, et al.
出版: (2025-07-01)
由: Ching-Yi Chuo, et al.
出版: (2025-07-01)
Immediate and delayed switches to tenofovir DF-containing, ainuovirine-based antiretroviral regimen: the SPRINT extensional study
由: Fujie Zhang, et al.
出版: (2025-09-01)
由: Fujie Zhang, et al.
出版: (2025-09-01)
eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort
由: Ramón Teira, et al.
出版: (2021-09-01)
由: Ramón Teira, et al.
出版: (2021-09-01)
Risks of metabolic syndrome in the ADVANCE and NAMSAL trials
由: Tamara Tovar Sanchez, et al.
出版: (2023-09-01)
由: Tamara Tovar Sanchez, et al.
出版: (2023-09-01)
Long-term efficacy and safety of tenofovir alafenamide, tenofovir disoproxil fumarate, and entecavir in treating hepatitis B virus-related acute-on-chronic liver failure: A 144-week data analysis
由: Yeqiong Zhang, et al.
出版: (2024-12-01)
由: Yeqiong Zhang, et al.
出版: (2024-12-01)
Comparative risk of osteoporosis and fractures in chronic hepatitis B patients: Tenofovir disoproxil fumarate vs. entecavir in a Korean nationwide cohort
由: Yoon E. Shin, et al.
出版: (2025-09-01)
由: Yoon E. Shin, et al.
出版: (2025-09-01)
Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection
由: Toni Herta, et al.
出版: (2022-04-01)
由: Toni Herta, et al.
出版: (2022-04-01)
Tenofovir Alafenamide Rescues Renal Tubules in Patients with Chronic Hepatitis B
由: Tomoya Sano, et al.
出版: (2021-03-01)
由: Tomoya Sano, et al.
出版: (2021-03-01)
Prevalence of Nephrotoxicity in HIV Patients Treated with Tenofovir Disoproxil Fumarate: A Single-center Observational Study
由: Kowthar Salman Hassan, et al.
出版: (2019-05-01)
由: Kowthar Salman Hassan, et al.
出版: (2019-05-01)
Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trial
由: Li-Xin Pan, et al.
出版: (2024-01-01)
由: Li-Xin Pan, et al.
出版: (2024-01-01)
Entecavir administration to pregnant Japanese woman with chronic hepatitis B and hepatocellular carcinoma: A case report
由: Toshihiko Kakiuchi, et al.
出版: (2021-03-01)
由: Toshihiko Kakiuchi, et al.
出版: (2021-03-01)
Effects of tenofovir alafenamide fumarate on serum lipid profiles in patients with chronic hepatitis B
由: Fei Cao, et al.
出版: (2024-09-01)
由: Fei Cao, et al.
出版: (2024-09-01)
相似書籍
-
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate in a cohort of patients with HBV infection: A retrospective study
由: Giacomo Stroffolini, et al.
出版: (2024-02-01) -
Reconsidering treatment indications for chronic hepatitis B: Insights from the TORCH-B roll-over study: Editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
由: Chih-Wen Wang, et al.
出版: (2025-04-01) -
Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study
由: Pei-Yuan Su, et al.
出版: (2021-11-01) -
Antiviral Efficacy and Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B
由: Tuvshinbayar Narangerel, et al.
出版: (2020-12-01) -
Cost–effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece
由: Emmanouil Sinakos, et al.
出版: (2024-02-01)
